Shorla Oncology
PrivateLast Round
VC Round
Jan 17, 2026
Total Funding Raised
$43.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Shorla Oncology is a pharmaceutical company that develops and commercializes innovative oncology drugs, with a focus on orphan and pediatric cancers where existing treatments are limited or in short supply.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shorla Oncology Comparables
Compare Shorla Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eagle Pharmaceuticals, Inc. | 78% | |
| Amneal Pharmaceuticals, Inc. | 70% | |
| Therakind Ltd | 68% | |
Shorla Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 17, 2026 | ||||
| Series B | Oct 4, 2023 | ||||
| Series A | Jun 3, 2020 |
Key People
Founding team and executive leadership
Shorla Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seroba Life Sciences | Series B, VC Round, Series A |
| Enterprise Ireland | Series B, VC Round, Series A |
| Kurma Partners | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 41% MoM, from 1.8K to 2.6K.
- Jan 27, 2026
$21M round completed.
Shorla Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shorla Oncology's valuation, stock price, and market status.